Matches in SemOpenAlex for { <https://semopenalex.org/work/W2425134118> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W2425134118 endingPage "7" @default.
- W2425134118 startingPage "4" @default.
- W2425134118 abstract "James M. Frincke of Hollis-Eden Pharmaceuticals is interviewed about HE2000, a chemical relative of DHEA which has shown antiretroviral activity in laboratory tests, that the company has developed. Instead of treating the virus, HE2000 is designed to treat the cells of the host. The drug has been credited with saving the lives of three monkeys in a small animal trial, and Phase I/II trials are underway in South Africa and the United States. The animal study findings are detailed. In the South African trial, HE2000 is given via injection for five days, followed by a 30-day observational period. In addition, the development of the drug and known side effects are described. HE2000 is still in the early stages of development; there is no timetable for possible FDA approval." @default.
- W2425134118 created "2016-06-24" @default.
- W2425134118 creator A5085488706 @default.
- W2425134118 date "1999-06-04" @default.
- W2425134118 modified "2023-09-23" @default.
- W2425134118 title "HE2000 begins clinical trials: interview with James Frincke, Ph.D. Interview by John S. James." @default.
- W2425134118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11366467" @default.
- W2425134118 hasPublicationYear "1999" @default.
- W2425134118 type Work @default.
- W2425134118 sameAs 2425134118 @default.
- W2425134118 citedByCount "0" @default.
- W2425134118 crossrefType "other" @default.
- W2425134118 hasAuthorship W2425134118A5085488706 @default.
- W2425134118 hasConcept C126322002 @default.
- W2425134118 hasConcept C15744967 @default.
- W2425134118 hasConcept C23131810 @default.
- W2425134118 hasConcept C2992672634 @default.
- W2425134118 hasConcept C3013748606 @default.
- W2425134118 hasConcept C512399662 @default.
- W2425134118 hasConcept C535046627 @default.
- W2425134118 hasConcept C71924100 @default.
- W2425134118 hasConceptScore W2425134118C126322002 @default.
- W2425134118 hasConceptScore W2425134118C15744967 @default.
- W2425134118 hasConceptScore W2425134118C23131810 @default.
- W2425134118 hasConceptScore W2425134118C2992672634 @default.
- W2425134118 hasConceptScore W2425134118C3013748606 @default.
- W2425134118 hasConceptScore W2425134118C512399662 @default.
- W2425134118 hasConceptScore W2425134118C535046627 @default.
- W2425134118 hasConceptScore W2425134118C71924100 @default.
- W2425134118 hasIssue "No 320" @default.
- W2425134118 hasLocation W24251341181 @default.
- W2425134118 hasOpenAccess W2425134118 @default.
- W2425134118 hasPrimaryLocation W24251341181 @default.
- W2425134118 hasRelatedWork W1510352682 @default.
- W2425134118 hasRelatedWork W178901227 @default.
- W2425134118 hasRelatedWork W1884192967 @default.
- W2425134118 hasRelatedWork W1954461468 @default.
- W2425134118 hasRelatedWork W1968436091 @default.
- W2425134118 hasRelatedWork W2040661167 @default.
- W2425134118 hasRelatedWork W2159155068 @default.
- W2425134118 hasRelatedWork W2403496762 @default.
- W2425134118 hasRelatedWork W2898406231 @default.
- W2425134118 hasRelatedWork W2073917454 @default.
- W2425134118 isParatext "false" @default.
- W2425134118 isRetracted "false" @default.
- W2425134118 magId "2425134118" @default.
- W2425134118 workType "other" @default.